3 Spinal Muscular Atrophy Clinical Trials in Lebanon, PA (2026)

Q: How do I join a clinical trial in Lebanon?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Lebanon research site will contact you.

Recruiting Spinal Muscular Atrophy Studies in Lebanon

NCT04165798Recruiting

KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)

This study is referred to as the "umbrella master protocol" for pembrolizumab (MK-3475) in the treatment of non-small cell lung cancer (NSCLC). This pembrolizumab NSCLC umbrella master protocol uses a...

Lebanon, PA1,065 participantsMerck Sharp & Dohme LLC

View Study Details

NCT07155187Recruiting

A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) is a common type of lung cancer where abnormal cells in the lungs grow out of control. The purpose of this study is to assess adverse events and change in disease ac...

Lebanon, PA490 participantsAbbVie

View Study Details

NCT04165070Recruiting

KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)

The purpose of this study is to assess the efficacy and safety of pembrolizumab (MK-3475) with or without chemotherapy in combination with vibostolimab (MK-7684), boserolimab (MK-5890), MK-4830, MK-04...

Lebanon, PA450 participantsMerck Sharp & Dohme LLC

View Study Details

About Spinal Muscular Atrophy Clinical Trials in Lebanon

Spinal muscular atrophy (SMA) is a genetic neuromuscular disorder that causes loss of motor neurons, leading to progressive muscle weakness and atrophy. It is the leading genetic cause of infant death. Revolutionary gene therapies and SMN-enhancing drugs have transformed treatment.

There are currently 3 spinal muscular atrophy clinical trials recruiting participants in Lebanon, PA. These studies are seeking a combined 2,005 participants. Research is being sponsored by Merck Sharp & Dohme LLC, AbbVie. Clinical trial participation is free and participants receive study-related medical care at no cost.

Spinal Muscular Atrophy Clinical Trials in Lebanon — FAQ

Are there spinal muscular atrophy clinical trials in Lebanon?

Yes, there are 3 spinal muscular atrophy clinical trials currently recruiting in Lebanon, PA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Lebanon?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Lebanon research site will contact you about next steps.

Are clinical trials in Lebanon free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Lebanon studies also compensate for your time and travel.

What spinal muscular atrophy treatments are being tested?

The 3 active trials in Lebanon are testing new therapies including novel drugs, biologics, and treatment approaches for spinal muscular atrophy.

Data updated July 13, 2026 from ClinicalTrials.gov